O
Oksana Yaskiv
Researcher at Hofstra University
Publications - 34
Citations - 824
Oksana Yaskiv is an academic researcher from Hofstra University. The author has contributed to research in topics: Prostate cancer & Nephrectomy. The author has an hindex of 11, co-authored 29 publications receiving 700 citations. Previous affiliations of Oksana Yaskiv include Smith Institute & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Improving Detection of Clinically Significant Prostate Cancer: Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Guided Prostate Biopsy
Ardeshir R. Rastinehad,Baris Turkbey,Simpa S. Salami,Oksana Yaskiv,Arvin K. George,Mathew Fakhoury,Karin Beecher,Manish Vira,Louis R. Kavoussi,David N. Siegel,Robert Villani,Eran Ben-Levi +11 more
TL;DR: The results of this trial support the external validity of this platform and may be the next step in the evolution of prostate cancer management.
Journal ArticleDOI
Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors.
Paras Shah,Daniel M. Moreira,Zhamshid Okhunov,Vinay Patel,Sameer Chopra,Aria Razmaria,Manaf Alom,Arvin K. George,Oksana Yaskiv,Michael J. Schwartz,Mihir M. Desai,Manish Vira,Lee Richstone,Jaime Landman,Arieh L. Shalhav,Inderbir S. Gill,Louis R. Kavoussi +16 more
TL;DR: Positive surgical margins after partial nephrectomy increase the risk of disease recurrence, primarily in patients with adverse pathological features.
Journal ArticleDOI
In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
Simpa S. Salami,Eran Ben-Levi,Oksana Yaskiv,Laura Ryniker,Baris Turkbey,Louis R. Kavoussi,Robert Villani,Ardeshir R. Rastinehad,Ardeshir R. Rastinehad +8 more
TL;DR: In this paper, the authors evaluated the performance of multiparametric magnetic resonance imaging (mpMRI) in predicting prostate cancer on repeat biopsy; and compared the cancer detection rates (CDRs) of MRI/transrectal ultrasonography (TRUS) fusion-guided biopsy with standard 12-core biopsy in men with at least one previous negative biopsy.
Journal ArticleDOI
The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.
Oksana Yaskiv,Xiaochun Zhang,Kelly Simmerman,Tom Daly,Huiying He,Sara M. Falzarano,Longwen Chen,Cristina Magi-Galluzzi,Ming Zhou +8 more
TL;DR: The P63/ERG double immunostain combines the high sensitivity of P63 and the high specificity of ERG and may be potentially useful in the work-up of difficult prostate biopsies.
Journal ArticleDOI
Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancer
Simpa S. Salami,Manish Vira,Baris Turkbey,Mathew Fakhoury,Oksana Yaskiv,Robert Villani,Eran Ben-Levi,Ardeshir R. Rastinehad,Ardeshir R. Rastinehad +8 more
TL;DR: The authors compared the performance of the PCPTHG against multiparametric magnetic resonance imaging (MP‐MRI) in predicting men at risk of CaP.